<DOC>
	<DOCNO>NCT00614120</DOCNO>
	<brief_summary>This trial conduct Asia . The trial design compare effect glycaemic control liraglutide glimepiride add metformin subject type 2 diabetes</brief_summary>
	<brief_title>Effect Liraglutide Glimepiride Added Metformin Blood Glucose Control Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Type 2 diabetes Subjects diagnose type 2 diabetes treat one oral antidiabetic drug ( OADs ) last 3 month HbA1c : 7.011.0 % ( incl . ) subject OAD alone HbA1c : 7.010.0 % ( incl . ) subject OAD combination therapy BMI le 45.0 kg/m^2 Treatment insulin within last 3 month prior trial Impaired liver or/and renal function Significant cardiovascular disease last 6 month Known retinopathy maculopathy Recurrent major hypoglycaemia hypoglycaemic unawareness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>